CompletedPhase 3NCT02707861
Ibalizumab Plus Optimized Background Regimen in Treatment-Experienced Patients With Multi-Drug Resistant HIV-1
Studying Acquired immunodeficiency
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- TaiMed Biologics Inc.
- Principal Investigator
- Stanley T. Lewis, MD, MPHTaiMed Biologics Inc.
- Intervention
- ibalizumab(drug)
- Enrollment
- 79 enrolled
- Eligibility
- 18 years · All sexes
- Timeline
- 2016 – 2018
Study locations (30)
- Long Beach Education and Research Consultants, Long Beach, California, United States
- Southern California Permanente Medical Group, Los Angeles, California, United States
- Ruane Clinical Research Institute Inc., Los Angeles, California, United States
- Charles R. Drew University of Medicine and Science, Clinical and Translational Research Center, Los Angeles, California, United States
- Anthony Mills MD Inc., Los Angeles, California, United States
- Palmtree Clinical Research, Inc., Palm Springs, California, United States
- eStudy Site, San Francisco, California, United States
- Kaiser Foundation Research Institute, San Francisco, California, United States
- Yale University, New Haven, Connecticut, United States
- Georgetown University School of Medicine, Washington D.C., District of Columbia, United States
- Gary Richmond, MD, PA, Fort Lauderdale, Florida, United States
- AIDS Healthcare Foundation - Kinder Medical Group, Miami, Florida, United States
- AIDS Healthcare Foundation - South Beach, Miami, Florida, United States
- Orlando Immunology Center, Orlando, Florida, United States
- Triple O Research Institute, West Palm Beach, Florida, United States
- +15 more locations on ClinicalTrials.gov
Collaborators
Westat
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT02707861 on ClinicalTrials.govOther trials for Acquired immunodeficiency
Additional recruiting or active studies for the same condition.
- RECRUITINGNANCT07298785Peer-led Dynamic Choice HIV Prevention for Women: The Peer-led DCP Pilot StudyUniversity of California, San Francisco
- ENROLLING BY INVITATIONNANCT07192419Promoting Aging and Thriving With HIVIndiana University
- ACTIVE NOT RECRUITINGEARLY PHASE1NCT07182838Proof-of-Concept Clinical Pharmacology Trial for HIV Antigen Presentation Therapeutic Biologic MixHan Xu, M.D., Ph.D., FAPCR, Sponsor-Investigator, IRB Chair
- RECRUITINGNANCT07064785Video-Intervention to Inspire Treatment Adherence for Life for AdolescentsBaylor College of Medicine
- RECRUITINGNANCT06999928Enhanced Mentor Mother Strategy for Pregnant and Postpartum Women Living With HIVIndiana University
- ACTIVE NOT RECRUITINGNANCT07074899Evaluation of a Multi-Component Intervention to Support HIV Testing and Linkage to Services Among MSM in PeruFred Hutchinson Cancer Center
- RECRUITINGNANCT06389565Change My Story Task Shifted Mental Health InterventionMassachusetts General Hospital
- ACTIVE NOT RECRUITINGNANCT06913660ALHIV Smartphone Game StudyEmory University